Multiple sclerosis trials in Germany

In Germany 39 Also abroad 503

14 of 39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
Where
Aachen, Amberg, Arnsdorf, Aschaffenburg, Bad Soden, Bamberg, Berg, Berlin, Bochum, Bogen, Buchholz, Celle, Chemnitz, Cologne, Dortmund, Düsseldorf, Eltville, Erbach/Odenwald, Erlangen, Essen, Forchheim, Frankfurt, Freiburg im Breisgau, Füssen, Giessen, Gladenbach, Günzburg, Halle, Hamburg, Hanover, Hennigsdorf, Herford, Hettingen, Ibbenbueren, Isselburg, Jena, Kiel, Leipzig, Lübeck, Magdeburg, Mannheim, Marburg, Meerbusch, Minden, München, Münster, Neuburg am Inn, Neuruppin, Neu-Ulm, Nuremberg, Öhringen, Osnabrück, Pforzheim, Quakenbrück, Regensburg, Remscheid, Rülzheim, Schwetzingen, Siegen, Singen, Sinsheim, Steglitz, Stuttgart, Sundern, Tübingen, Ulm, Unterhaching, Weil der Stadt, Wolfratshausen, Zwickau
Age
18 years and over
People
842 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06780150
No phaseEnrolling by invitation
MS-Related Disability Worsening and Thalamic Volume Loss
Where
Dresden, Multiple Locations
Age
18 years to 55 years
People
2,400
Run by
Jung Diagnostics GmbH
See details and how to joinNCT07753928
No phaseTaking people
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Where
Bochum
People
908 worldwide
Run by
Biogen
See details and how to joinNCT05658497
No phaseTaking people
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Where
Aalen, Albstadt, Altenburg, Altenholz, Altmark, Alzey, Bad Homburg, Bamberg, Bayreuth, Bergneustadt, Berlin, Böblingen, Bochum, Bogen, Bonn, Braunschweig, Bremen, Chemnitz, Coburg, Cologne, Crailsheim, Dessau, Dillingen an der Donau, Dillingen Saar, Dortmund, Dresden, Duisburg, Düsseldorf, Eisleben Lutherstadt, Eltville, Erbach im Odenwald, Erfurt, Erlangen, Essen, Falkensee, Frankfurt am Main, Fulda, Gelsenkirchen, Giessen, Gladenbach, Görlitz, Hagen, Halle, Hamburg, Hanover, Hettingen, Höxter, Ingelheim, Itzehoe, Jena, Kaiserslautern, Karlsruhe, Leipzig, Lünen, Magdeburg, Mannheim, Marburg, Meerbusch, Merzig, Mettmann, Minden, Montabaur, Mühlhausen, Mülheim, München, Munich, Münster, Nagold, Neuburg A.d. Donau, Neuruppin, Nuremberg, Oer-Erkenschwick, Oldenburg, Osnabrück, Pforzheim, Potsdam, Regensburg, Remscheid, Rostock, Rüdersdorf, Rülzheim, Saarlouis, Salzatal, Schiltach, Schneverdingen, Schwäbisch Hall, Schwetzingen, Siegen, Sinsheim, Stadtroda, Stuttgart, Tirschenreuth, Trier, Tübingen, Unterhaching, Untermeitingen, Velbert, Weil der Stadt, Wildeshausen, Wolfratshausen
Age
18 years to 100 years
People
800
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05344469
No phaseTaking people
Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
Where
Düsseldorf, Mönchengladbach
Age
18 years to 79 years
People
837
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT07426991
Phase 2/3Taking people
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Where
Berlin, Bochum, Hamburg, Hanover
Age
18 years and over
People
70 worldwide
Run by
Kyverna Therapeutics
See details and how to joinNCT07403188 · EU 2024-511198-31-00
No phaseTaking people
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Where
Berlin, Bochum
Age
18 years and over
People
7,000 worldwide
Run by
icometrix
See details and how to joinNCT06280755
No phaseTaking people
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Where
Herne
People
1,182 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05170126
No phaseEnrolling by invitation
Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)
Where
Hanover
Age
18 years to 70 years
People
1,142
Run by
Skripuletz, Thomas Prof. Dr.
See details and how to joinNCT07183020
No phaseTaking people
Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
Where
Düsseldorf
Age
18 years to 60 years
People
100
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06586177
No phaseTaking people
Smart Monitoring Assessing Spasticity-related Health
Where
Düsseldorf
Age
18 years and over
People
46
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06937723
No phaseTaking people
Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach
Where
Düsseldorf
Age
18 years and over
People
77
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06501950
No phaseTaking people
Pregnancy Cohort in Multiple Sclerosis (MS)
Where
Berlin
Age
18 years to 50 years
People
100
Run by
Charite University, Berlin, Germany
See details and how to joinNCT05010902
No phaseTaking people
Strategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple Sclerosis
Where
Düsseldorf
Age
18 years and over
People
150
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06461481